Cover Image
Market Research Report

Orthopedic Biomaterials | US | 2016 | Market Analysis

Published by Millennium Research Group Product code 225459
Published Content info 167 Pages
Delivery time: 1-2 business days
Price
Back to Top
Orthopedic Biomaterials | US | 2016 | Market Analysis
Published: December 22, 2015 Content info: 167 Pages
Comment
Despite recent obstacles, such as product approval denials, changes to treatment recommendations and a challenging economic environment, ongoing adoption of these products continues and overall interest in the use of these products remains high.
Description

Despite ongoing obstacles to growth, such as changes to treatment recommendations, challenging reimbursement environments, and negative publicity surrounding significant products, the US market for orthopedic biomaterials will show sustained and improving growth comparable to other large orthopedic markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in the US across a 10-year period.

Questions Answered in This Report:

  • The BGS market continues to be negatively impacted by ongoing issues surrounding INFUSE, although the introduction of new products, such as i-Factor and Augment, will help offset this trend.
    • Which material segments will benefit from declining use of growth factor products?
    • How will growth of the overall BGS market be impacted by this change in product mix?
  • The recent and continuing introduction of products and expanded indications in the HA viscosupplementation market will drive market growth.
    • How will the introduction of new products help offset the negative recommendation against HA injections by the AAOS?
    • How will the nonknee market segment expand following the anticipated approval of these indications?
  • Despite a lack of consensus in the clinical data surrounding cell concentration systems, procedure volumes will continue to show moderate growth.
    • Which orthopedic procedure segments generate the highest proportion of cell concentration system unit sales?
    • What strategies are competitors using to expand product penetration and market share in this market?
Table of Contents
Product Code: RPUS20OB15

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1. Orthopedic Biomaterial Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Market Shares
  • 1.7. Market Factors and Developments

2. Bone Graft Substitute Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
    • 2.3.1. By Material
      • 2.3.1.1. Growth Factors
      • 2.3.1.2. Demineralized Bone Matrices
      • 2.3.1.3. Orthopedic Stem Cell Products
      • 2.3.1.4. Nonproprietary Allografts
      • 2.3.1.5. First- and Second-Generation Synthetics
    • 2.3.2. By Procedure Type
      • 2.3.2.1. Spinal Fusion
        • 2.3.2.1.1. By Approach
        • 2.3.2.1.2. By Anatomy
          • 2.3.2.1.2.1. Thoracolumbar
          • 2.3.2.1.2.2. Cervical
      • 2.3.2.2. Trauma Surgery
      • 2.3.2.3. Large-Joint Revision and Reconstruction
      • 2.3.2.4. Extremity Surgery
      • 2.3.2.5. Craniomaxillofacial Surgery
  • 2.4. General Market Trends
    • 2.4.1. By Material
      • 2.4.1.1. Growth Factors
      • 2.4.1.2. Allografts
      • 2.4.1.3. Synthetics
      • 2.4.1.4. Xenografts
      • 2.4.1.5. Orthopedic Stem Cell
    • 2.4.2. By Procedure Type
      • 2.4.2.1. Spinal Fusion Products
      • 2.4.2.2. Trauma Surgery
      • 2.4.2.3. Large-Joint Revision and Reconstruction
      • 2.4.2.4. Extremity Surgery
      • 2.4.2.5. Craniomaxillofacial Surgery
  • 2.5. Competitive Highlights
  • 2.6. Competitive Landscape
  • 2.7. Market Shares

3. Hyaluronic Acid Viscosupplementation

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
    • 3.3.1. By Number of Injections
    • 3.3.2. By Anatomy
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Competitive Landscape
  • 3.7. Market Shares

4. Cell Concentration System Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Competitive Landscape
  • 4.7. Market Shares

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

Back to Top